Clinical Trial Update: Social Anxiety Disorder Study Of Paroxetine [Phase 3]

View source ↗

Summary

A Phase 3 trial of paroxetine for social anxiety disorder (social phobia) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Social Phobia | Phase 3 | Status: COMPLETED